HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$4.43
Day range
$4.11 - $4.54
Year range
$2.01 - $15.60
Market cap
7.81M USD
Avg Volume
138.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.54M | -3.29% |
Operating expense | 1.15M | -34.41% |
Net income | -708.99K | 47.30% |
Net profit margin | -27.87 | 45.51% |
Earnings per share | — | — |
EBITDA | -740.85K | 46.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.89M | -30.03% |
Total assets | 7.62M | -30.68% |
Total liabilities | 804.97K | -49.91% |
Total equity | 6.82M | — |
Shares outstanding | 1.80M | — |
Price to book | 1.17 | — |
Return on assets | -22.59% | — |
Return on capital | -26.03% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -708.99K | 47.30% |
Cash from operations | -1.24M | 22.80% |
Cash from investing | 994.65K | 589.59% |
Cash from financing | 34.19K | 161.07% |
Net change in cash | -180.10K | 86.11% |
Free cash flow | -974.02K | 25.03% |
About
Founded
2017
Website
Employees
30
